Grupo de Investigación en Cáncer de Mama
NEONCOBREAST
![Foto de Grupo de Investigación en Cáncer de Mama](/img/uploaded/46084eb269a9135ee7dc8a58bb36982a.jpg)
![Foto de University of North Carolina at Chapel Hill](/img/noimage_org.png)
University of North Carolina at Chapel Hill
Chapel Hill, Estados UnidosPublicaciones en colaboración con investigadores/as de University of North Carolina at Chapel Hill (2)
2014
-
Effect of p95HER2/611CTF on the response to trastuzumab and chemotherapy
Journal of the National Cancer Institute, Vol. 106, Núm. 11
2012
-
PI3K inhibition impairs BRCA1/2 expression and sensitizes BRCA-proficient triple-negative breast cancer to PARP inhibition
Cancer Discovery, Vol. 2, Núm. 11, pp. 1036-1047